Curium Enrolls First Prostate Cancer Patients in its Phase 3 SOLAR Trials
ST. LOUIS, April 23, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has successfully enrolled and scanned patients in its SOLAR clinical trials: The first trial is SOLAR-STAGE: a Phase 3, multicenter, open- …